首页 > 最新文献

International Journal of Endocrinology: Diabetes and Metabolism最新文献

英文 中文
Body Fat Removal 去除体脂
Pub Date : 2021-12-07 DOI: 10.55124/ijde.v1i1.150
Michael V. Tyurin
Food fat gets distributed in the blood and therefore may be removed from the blood.  Fat removal is simple and efficient using the blood circulation through the blood fat removal column described herein. The resulting body weight after 20 blood fat removal procedures might be 230 lbs.  The patient has reached her body size fitting the suits purchased before the weight accumulation
食物中的脂肪分布在血液中,因此可以从血液中清除。通过本文所述的血脂去除柱,利用血液循环去除脂肪是简单而有效的。20次去脂手术后的体重可能是230磅。患者的体型已经达到了与体重积累前购买的套装相匹配的尺寸
{"title":"Body Fat Removal","authors":"Michael V. Tyurin","doi":"10.55124/ijde.v1i1.150","DOIUrl":"https://doi.org/10.55124/ijde.v1i1.150","url":null,"abstract":"Food fat gets distributed in the blood and therefore may be removed from the blood.  Fat removal is simple and efficient using the blood circulation through the blood fat removal column described herein. The resulting body weight after 20 blood fat removal procedures might be 230 lbs.  The patient has reached her body size fitting the suits purchased before the weight accumulation","PeriodicalId":163207,"journal":{"name":"International Journal of Endocrinology: Diabetes and Metabolism","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115486026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rejection of vaccination against the COVID-19 virus will increase morbidity and mortality 拒绝接种COVID-19病毒疫苗将增加发病率和死亡率
Pub Date : 2021-11-10 DOI: 10.55124/ijde.v1i1.134
Mohammadreza Rezaeipour
It has been about two years since the first COVID-19 epidemic began,now it coincides with the fifth peak of epidemic infection in some countries. Over the years we have experienced many ups and downs of this virus(1, 2).It has been about two years since the first COVID-19 epidemic began,now it coincides with the fifth peak of epidemic infection in some countries. Over the years we have experienced many ups and downs of this virus(1, 2). Some people are still with us, but unfortunately, some have left us in the middle of their lives, and they have become victims of the COVID-19 pandemic(3). A virus that when it got into the world of people, many said: "It does not last long and when it reaching warm seasons of the year, it will die prematurely and does not survive." However, the virus has survived to this today.Efforts have been made around the world to shine the bright rays of hope and life in the shady cornerscreated by it(4, 5). One of these constructive efforts is to obtain a vaccine against COVID-19.  COVID-19 vaccination rates have still not been optimal in some countries(6, 7). While China, India, and the United States have had the highest vaccination rates (over 100%) since August 4, 2021, the statistics are disappointing in some other countries(8). For example, approximately 1.16% of Iranians received vaccinations at the same time(6-8). This is not sufficient to achieve so-called herd immunity, and hospitals have become more crowded due to the serious spread of the more contagious type of delta.In addition to the lack of appropriate vaccines due to economic sanctions following the political tensions in some countries,such as Iran(9, 10), the reasons for refusing free injections and neglecting preventive measures are alsodifferent(5). The covid-19 virus survived and mutant and increased mortality. However, still, some people don't hear and look at these facts. The efforts of medical staff across the globe have not yet been properly heard(5). What remains are the challenges that have endangered human life on earth, and we seem to be counting it down. These barriers must be identified in a short time. The workload of medical staff has grown significantly. In addition, journalists and the press have come to their aid, reporting and promoting the views of professors, experts, and heads of the health care system in the press, and enlightenment efforts have reached the point where politicians are talking about COVID-19 in election campaigns(11). Although an unknown and difficult path has been taken so far, it seems that this path is still ahead(7). In addition to government agencies, removing these barriers requires residents' campaigns to get vaccinated for their health, for their grandparents, for their neighbors, or to use free incentives(5, 12).Failure to do so will result in significant health costs for governments and economies.Failure to get COVID-19 vaccination in most cases leads to hospitalization and usually leads to large bills.
自第一次COVID-19疫情开始以来,已经过去了大约两年,现在恰逢一些国家的第五个流行病感染高峰。多年来,我们经历了这种病毒的多次起伏(1,2),第一次COVID-19流行已经过去两年左右,现在恰逢一些国家的第五个流行感染高峰。多年来,我们经历了这种病毒的许多起起伏伏(1,2)。有些人仍然和我们在一起,但不幸的是,有些人在生命的中途离开了我们,他们成为了COVID-19大流行的受害者(3)。当这种病毒进入人类世界时,许多人说:“它不会持续很长时间,当它到达一年中的温暖季节时,它会过早死亡,无法存活。”然而,病毒已经存活到今天。世界各地都在努力让希望和生命的光芒照亮它所创造的阴暗角落(4,5)。这些建设性的努力之一就是获得新冠病毒疫苗。一些国家的COVID-19疫苗接种率仍未达到最佳水平(6,7)。尽管中国、印度和美国自2021年8月4日以来的疫苗接种率最高(超过100%),但其他一些国家的统计数据令人失望(8)。例如,大约1.16%的伊朗人同时接种了疫苗(6-8)。这不足以实现所谓的群体免疫,而且由于传染性更强的三角洲病毒的严重传播,医院变得更加拥挤。除了一些国家(如伊朗)在政治紧张局势之后由于经济制裁而缺乏适当的疫苗(9,10)之外,拒绝免费注射和忽视预防措施的原因也各不相同(5)。covid-19病毒存活并变异,死亡率上升。然而,仍然有一些人没有听到和看到这些事实。全球医务人员的努力尚未得到适当的倾听(5)。剩下的是威胁地球上人类生命的挑战,我们似乎正在倒计时。必须在短时间内确定这些障碍。医务人员的工作量大大增加。此外,记者和媒体也提供了帮助,在媒体上报道和宣传教授、专家和保健系统负责人的观点,政治家们在竞选活动中谈论COVID-19的启蒙努力也达到了这样的程度(11)。尽管到目前为止,我们已经走了一条未知而艰难的道路,但似乎这条道路仍在前方(7)。除政府机构外,消除这些障碍还需要居民为自己的健康、祖父母、邻居接种疫苗,或使用免费奖励措施(5,12)。如果不这样做,将给政府和经济体带来巨大的卫生成本。在大多数情况下,未能接种COVID-19疫苗会导致住院,通常会导致大笔账单。对于没有保险的人,这些费用会更高。它还增加了其突变株再次全球化大流行的可能性(13)。参考文献:Ferrer, R COVID-19大流行:重症监护史上最大的挑战。药物intensiva。2020年,44(6):323。他,j .;陈,g;江,y;金,r;Shortridge, a;Agusti, S等。中国、韩国、意大利和伊朗COVID-19传播模式的比较感染模型和控制环境科学。2020;47:141447。股票,广告。巴德,呃。Cezayirli p;Inocencio, j .;Chalmers SA, Yassari R,等。卫生保健工作者中COVID-19感染:支持常规检测的血清学结果医学前沿。2020; 7:471。与2019冠状病毒病相关的学龄儿童体重增加。国际内分泌与代谢杂志,2021;19(1)。拉撒路,合资企业。Ratzan, SC。Palayew, a;Gostin瞧。拉森,HJ。;拉宾、凯等人。对COVID-19疫苗潜在接受度的全球调查。自然医学。2021; 27(2): 225 - 8。王晓明,王晓明。国外疫苗生产现状及伊朗新冠肺炎疫苗生产面临的科研挑战。细胞生物学学报,2011:1749 -56。7.Maserat大肠;Keikha l;•美国;Mohammadzadeh, Z.伊朗COVID- 19疫苗覆盖的电子卫生路线图。中华医学会公共卫生杂志,2011;21(1):1-11。马修,大肠;里奇,h;Ortiz-Ospina大肠;拱形门,m;Hasell, j .;阿佩尔,C等人。全球COVID-19疫苗接种数据库。自然,人类行为。2021:1-7。经济制裁对目标国家弱势群体福祉的影响。国际经济金融与可持续发展,2019;1(1):17-20。Setayesh,美国;麦基,TK。在《联合综合行动计划》中处理经济制裁对伊朗药品短缺的影响:促进获得药品和卫生外交。全球化和健康。2016; 12(1): 1 - 14。 阿托恩,m;跨国盗贼统治与COVID-19大流行如何遏制传播?跨国盗贼统治与遏制新冠肺炎疫情的传播。20121:4。保罗,大肠;斯特普托,a;Fancourt d;对疫苗的态度和接种COVID-19疫苗的意向:对公共卫生传播的影响。《柳叶刀-欧洲区域卫生》。2021; 1:100012。Desapriya大肠;Parisa k;截至2021年4月中旬,全球COVID-19死亡人数已超过300万。2021.
{"title":"Rejection of vaccination against the COVID-19 virus will increase morbidity and mortality","authors":"Mohammadreza Rezaeipour","doi":"10.55124/ijde.v1i1.134","DOIUrl":"https://doi.org/10.55124/ijde.v1i1.134","url":null,"abstract":"It has been about two years since the first COVID-19 epidemic began,now it coincides with the fifth peak of epidemic infection in some countries. Over the years we have experienced many ups and downs of this virus(1, 2).\u0000It has been about two years since the first COVID-19 epidemic began,now it coincides with the fifth peak of epidemic infection in some countries. Over the years we have experienced many ups and downs of this virus(1, 2). Some people are still with us, but unfortunately, some have left us in the middle of their lives, and they have become victims of the COVID-19 pandemic(3). A virus that when it got into the world of people, many said: \"It does not last long and when it reaching warm seasons of the year, it will die prematurely and does not survive.\" However, the virus has survived to this today.\u0000Efforts have been made around the world to shine the bright rays of hope and life in the shady cornerscreated by it(4, 5). One of these constructive efforts is to obtain a vaccine against COVID-19.  COVID-19 vaccination rates have still not been optimal in some countries(6, 7). While China, India, and the United States have had the highest vaccination rates (over 100%) since August 4, 2021, the statistics are disappointing in some other countries(8). For example, approximately 1.16% of Iranians received vaccinations at the same time(6-8). This is not sufficient to achieve so-called herd immunity, and hospitals have become more crowded due to the serious spread of the more contagious type of delta.\u0000In addition to the lack of appropriate vaccines due to economic sanctions following the political tensions in some countries,such as Iran(9, 10), the reasons for refusing free injections and neglecting preventive measures are also\u0000different(5). The covid-19 virus survived and mutant and increased mortality. However, still, some people don't hear and look at these facts. The efforts of medical staff across the globe have not yet been properly heard(5). What remains are the challenges that have endangered human life on earth, and we seem to be counting it down. These barriers must be identified in a short time. The workload of medical staff has grown significantly. In addition, journalists and the press have come to their aid, reporting and promoting the views of professors, experts, and heads of the health care system in the press, and enlightenment efforts have reached the point where politicians are talking about COVID-19 in election campaigns(11). Although an unknown and difficult path has been taken so far, it seems that this path is still ahead(7). In addition to government agencies, removing these barriers requires residents' campaigns to get vaccinated for their health, for their grandparents, for their neighbors, or to use free incentives(5, 12).\u0000Failure to do so will result in significant health costs for governments and economies.Failure to get COVID-19 vaccination in most cases leads to hospitalization and usually leads to large bills.","PeriodicalId":163207,"journal":{"name":"International Journal of Endocrinology: Diabetes and Metabolism","volume":"145 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115906719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Natural Competence for Transformation in Lactobacili 乳杆菌的自然转化能力
Pub Date : 2021-10-25 DOI: 10.55124/ijde.v1i1.119
M. Tyurin
We have detected the changes in the molecular biologic properties of the lascobacilus strain Lactibacillus buchneri NRRLB1837 after its storage in the lyophilized state using some patented lyophilization media.  The change noticed was the 3 orders of magnitude decrease of the natural competence for the genetic transformation capability of said lac-tobacillus strain.  Using noted difference we have transformed L. buchneri NRRLB1837 with the largest plasmid of Lactobacillus casei MT205, possessing strong antibacterial activity against gram-positive, gram-negative bacteria and Candida albicans.  The trans formants became resistant to Erythromycin (30 mcg/ml) and also had strong antibacterial activity, just like L. casei MT205, which was extractable from the concentrated by the evaporation cultural fluid of the respective transformants, The role of the lyophilization medium on the molecular biological properties of the lactobacilli stored lyophilized is dis-cussed. Introduction We have noticed about three orders in magnitude difference in the natural transfroma-tion capability in the strain of Lactobacillus buchneri NRRLB1837 depending on the par-ticular conditions of its lyophilization.  Said difference is esssential, since sometimes the natural capability to uptake the foreign plasmid DNA gets below the threshold of de-tection and may not be noticed.  We have detected, that for the strain of Lactobacillus buchneri NRRLB1837 such activity is the highest, if the lyophilization was performed using standard lyophilization medium comprising only sucrose and gelatin, but not the 0.1 M Trtis (pH8.0) and 10% adonit [1]. Routinely, deep freezers (-80oC) are used for the prolonged storage of the microbial cultures under the normal room temperatures.  However, most of the shipments are performed with the microbial cultures, lyophilized for the long-term storage.  We have noticed significant difference in the natural transforma-tion capability of Lactobacillus buchneri NRRLB1837 depending on the composition of the medium for its freeze drying. In particular, we noticed significant decrease of the natural genetic transformation capability in Lactobacillus buchneri NRRLB1837 depend-ing on the compositon of the medium for its freeze drying.  The decrease of that capabil-ity by three orders of magnitude was observed for the freeze dryed culture of said lacto-   bacilli freeze dryed in our patented medium for the freeze drying [1].  The core of our patent was the neutralization of the organic acids produced enormously by the intestinal lactobacilli by the 0.1 M Tris buffer (pH8.0) and the lyophilization viability was substan-tially (by 90%) increased when we added some cryoprotective sugar up to 10 vol % to said 0.1 M Tris buffer (autoclaved at 120oC for 30 min).  Today we have faced the fact, that the natural competence of the plasmid DNA uptake reported by us earlier [2] was accompanied with the decreased frequency of the genetic transfer for the plasmid DNA
bucheri NRRLB1837,该质粒立即提供了4 kb、8 kb、12 kb、24 kb大小的质粒DNA分子,而不是用于干酪乳杆菌MT205转化质粒的原始大小(约120 kb[4])。讨论了冻干培养基组成对冻干后保存的乳酸菌分子生物学特性的影响。材料与方法在Lactobacillus MRS Medium[4]培养基中培养乳酸菌,维持其生长、培养基、选择性抗生素。对于平板,将1.25%的琼脂加入MRS培养基中,然后在120℃下高压灭菌30分钟。为了选择带有质粒DNA pCB20的转化子,我们在MRS琼脂中分别加入红霉素(Em)和林可霉素(Lm),各20mcg/ml,然后进行高压灭菌并冷却至45℃,然后倒入100 mm培养皿[6]。将抗生素粉末按100 mg /支无菌加入无菌Eppendorf管[7]中,并按1 ml /支向无菌Eppendorf管中加入无菌ddH2O。在层流柜[8]中干燥所倒的培养皿,接种按所述[3]制备的天然转化菌。为了在培养皿表面传播变形菌,只使用无菌塑料环。为便于计算转化效率,只使用自然转化样品的七、六、五十进制稀释倍数。为了制备所述自然变压器样品的十进制稀释液,我们使用了db[10]。DB组成:0.1 M Tris, 0.15 M NaCl, 1.0 M尿素,10 mM CaCl2, 0.1 M一水柠檬酸,5 g牛血清白蛋白,1.0 g半胱氨酸-盐酸(pH 6.00)。用高压灭菌法在1atm下灭菌30min,用900微升[10]将DB分散到无菌的1.5 ml埃彭多夫管中。将得到的0.1 ml自然转化样品转移到含有900微升DB(所述样品的第二次稀释)的第二个Eppendorf管中,以此类推,以便对志愿者的粪便进行电镀十倍稀释。稀释粪便的步骤如下。将自然转化样品第一次稀释后的100微升等分液[11]加入到第二个1.5ml的Eppendorf管中,加入900微升DB等,分别进行第二次、第三次、第四次、第五次、第六次、第七次等稀释。从最后一次稀释受体细胞/自然转化体开始接种,以节省塑料微生物循环的用量。受体细胞的浓度在上述实验的五次重复中确定(为了适当的实验统计目的)。为此目的,如上所述制备了受体细胞的十进制稀释液,另外添加了受体细胞的第七、第八和第九稀释液。从最后一次稀释受体细胞开始进行接种,以节省使用的微生物循环量。如所述重复冻干。为了对我们的数据进行适当的统计分析,我们将布氏乳杆菌NRRLB 1837的培养物在俄罗斯科学院的收藏中保存了五次,我们重复了冻干过程,然后将相同的乳酸菌培养物冻干,因为它写在我们的专利中。该菌株从冻干状态中恢复,并用于实验,以揭示在俄罗斯科学院条件下冻干后自然转化能力的频率,并根据我们的专利# 1652336[1]。遗传转化前凝胶中提取的最大质粒DNA(约120 kb)的布氏乳杆菌NRRLB1837转化72h培养液的浓度,在100 ml MRS肉液中,37℃下培养72h;培养液在真空蒸发器[16]中进行真空蒸发。结果在5个独立实验中确定了受体细胞的浓度,对数据进行了适当的统计分析。所以,在我们所有的实验中,浓度从9 × 109到7 × 109不等。利用标准质粒DNA pCB20对布氏乳杆菌NRRLB1837进行遗传转化的自然转化效率评价用标准质粒DNA pCB20转染布氏乳杆菌NRRLB1837的受体细胞,发现了布氏乳杆菌NRRLB1837的emlmr抗性转化子,每用于该实验的受体细胞数量的emlmr抗性转化子的频率为9x10-5(数据为5个独立的遗传转化实验,以进行适当的统计评估)。L.细胞的遗传转化。
{"title":"Natural Competence for Transformation in Lactobacili","authors":"M. Tyurin","doi":"10.55124/ijde.v1i1.119","DOIUrl":"https://doi.org/10.55124/ijde.v1i1.119","url":null,"abstract":"We have detected the changes in the molecular biologic properties of the lascobacilus strain Lactibacillus buchneri NRRLB1837 after its storage in the lyophilized state using some patented lyophilization media.  The change noticed was the 3 orders of magnitude decrease of the natural competence for the genetic transformation capability of said lac-tobacillus strain.  Using noted difference we have transformed L. buchneri NRRLB1837 with the largest plasmid of Lactobacillus casei MT205, possessing strong antibacterial activity against gram-positive, gram-negative bacteria and Candida albicans.  The trans formants became resistant to Erythromycin (30 mcg/ml) and also had strong antibacterial activity, just like L. casei MT205, which was extractable from the concentrated by the evaporation cultural fluid of the respective transformants, The role of the lyophilization medium on the molecular biological properties of the lactobacilli stored lyophilized is dis-cussed. \u0000Introduction \u0000We have noticed about three orders in magnitude difference in the natural transfroma-tion capability in the strain of Lactobacillus buchneri NRRLB1837 depending on the par-ticular conditions of its lyophilization.  Said difference is esssential, since sometimes the natural capability to uptake the foreign plasmid DNA gets below the threshold of de-tection and may not be noticed.  We have detected, that for the strain of Lactobacillus buchneri NRRLB1837 such activity is the highest, if the lyophilization was performed using standard lyophilization medium comprising only sucrose and gelatin, but not the 0.1 M Trtis (pH8.0) and 10% adonit [1]. Routinely, deep freezers (-80oC) are used for the prolonged storage of the microbial cultures under the normal room temperatures.  However, most of the shipments are performed with the microbial cultures, lyophilized for the long-term storage.  We have noticed significant difference in the natural transforma-tion capability of Lactobacillus buchneri NRRLB1837 depending on the composition of the medium for its freeze drying. In particular, we noticed significant decrease of the natural genetic transformation capability in Lactobacillus buchneri NRRLB1837 depend-ing on the compositon of the medium for its freeze drying.  The decrease of that capabil-ity by three orders of magnitude was observed for the freeze dryed culture of said lacto- \u0000  \u0000bacilli freeze dryed in our patented medium for the freeze drying [1].  The core of our patent was the neutralization of the organic acids produced enormously by the intestinal lactobacilli by the 0.1 M Tris buffer (pH8.0) and the lyophilization viability was substan-tially (by 90%) increased when we added some cryoprotective sugar up to 10 vol % to said 0.1 M Tris buffer (autoclaved at 120oC for 30 min).  Today we have faced the fact, that the natural competence of the plasmid DNA uptake reported by us earlier [2] was accompanied with the decreased frequency of the genetic transfer for the plasmid DNA ","PeriodicalId":163207,"journal":{"name":"International Journal of Endocrinology: Diabetes and Metabolism","volume":"1202 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124793818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression in situ of the recombinant human erythropoetin and recombinant insulin. 重组人促红细胞生成素和重组胰岛素的原位表达。
Pub Date : 2021-09-10 DOI: 10.55124/ijde.v1i1.135
Michael V. Tyurin
{"title":"Expression in situ of the recombinant human erythropoetin and recombinant insulin.","authors":"Michael V. Tyurin","doi":"10.55124/ijde.v1i1.135","DOIUrl":"https://doi.org/10.55124/ijde.v1i1.135","url":null,"abstract":"","PeriodicalId":163207,"journal":{"name":"International Journal of Endocrinology: Diabetes and Metabolism","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123943632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Endocrinology: Diabetes and Metabolism
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1